• Quarterly net income attributable to the Partnership of $13.7 million; MLP distributable cash flow of $16.4 million
  • Increased quarterly cash distribution by 2.9% sequentially, or 12% compared to the second quarter 2018 distribution, to $0.4579 per unit, the 18th consecutive quarterly increase in distributions

HOUSTON--(BUSINESS WIRE)--Aug. 6, 2019-- Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") today reported net income attributable to the Partnership of $13.7 million, or $0.39 per limited partner unit, for the three months ended June 30, 2019, an increase of $0.9 million compared to second quarter 2018 net income attributable to the Partnership of $12.8 million. The increase in net income attributable to the Partnership was primarily due to the Partnership's increased ownership interest in Westlake Chemical OpCo LP ("OpCo"), partially offset by lower margins on third party sales and one-time costs associated with the acquisition of an incremental interest in OpCo. Cash flows from operating activities in the second quarter of 2019 were $100.2 million, a decrease of $14.2 million compared to second quarter 2018 cash flows from operating activities of $114.4 million. This decrease was primarily attributable to lower margins on third party sales and an increase in working capital. For the three months ended June 30, 2019, MLP distributable cash flow of $16.4 million increased by $0.4 million from second quarter 2018 MLP distributable cash flow of $16.0 million. This increase was primarily due to the increased ownership interest in OpCo, partially offset by the timing of maintenance capital expenditures and one-time costs associated with the acquisition of incremental interest in OpCo.

Second quarter 2019 net income attributable to the Partnership of $13.7 million decreased by $1.3 million from first quarter 2019 net income attributable to the Partnership of $15.0 million, primarily due to one-time costs associated with the acquisition of incremental interest in OpCo and higher interest expense, partially offset by higher production at OpCo. Second quarter 2019 cash flows from operating activities of $100.2 million decreased by $13.3 million compared to first quarter 2019 cash flows from operating activities of $113.5 million, primarily due to an increase in working capital, partially offset by higher production volumes at OpCo. Second quarter 2019 MLP distributable cash flow of $16.4 million decreased by $1.2 million compared to first quarter 2019 MLP distributable cash flow of $17.6 million, primarily due to one-time costs associated with the acquisition of incremental interest in OpCo and higher interest expense, partially offset by higher production at OpCo.

Net income attributable to the Partnership of $28.7 million, or $0.85 per limited partner unit, for the six months ended June 30, 2019 increased by $3.6 million compared to the first six months of 2018 net income attributable to the Partnership of $25.1 million. The increase in net income attributable to the Partnership as compared to the prior-year period was due to the Partnership's increased ownership interest in OpCo and increased production at OpCo, partially offset by lower margins on third party sales, the timing of maintenance capital expenditures and expenses associated with the acquisition of incremental interest in OpCo. Cash flows from operating activities in the first six months of 2019 were $213.7 million, a decrease of $6.9 million compared to the first six months of 2018 cash flows from operating activities of $220.6 million. This decrease was due to lower margins on third party sales, partially offset by a decrease in working capital. For the six months ended June 30, 2019, MLP distributable cash flow of $34.0 million increased by $3.5 million compared to the first six months of 2018 MLP distributable cash flow of $30.5 million. The increase in MLP distributable cash flow as compared to the prior-year period was due to the Partnership's increased ownership in OpCo and higher production, partially offset by the timing of maintenance capital expenditures and one-time costs associated with the acquisition of an incremental interest in OpCo.

On March 27, 2019, the Board of Directors of Westlake Chemical Partners GP LLC announced that it had agreed to acquire an additional 4.5% limited partner interest in OpCo on a fully diluted basis for approximately $201.4 million. The Partnership financed the acquisition with borrowings under its revolving credit facility and the proceeds of a private placement of 2,940,818 common units. The acquisition increased the Partnership's limited partner interest in OpCo to approximately 22.8% and represented the third purchase of additional interests in OpCo by the Partnership since the Partnership's initial public offering. The acquisition was effective January 1, 2019 and was immediately accretive to the Partnership's distributable cash flow.

On July 31, 2019, the Board of Directors of Westlake Chemical Partners GP LLC announced a quarterly distribution with respect to the second quarter of 2019 of $0.4579 per unit to be payable on August 26, 2019 to unitholders of record as of August 12, 2019. The second quarter 2019 distribution increased by 12% compared to the second quarter 2018 distribution and by 2.9% compared to the first quarter 2018 distribution. MLP distributable cash flow provided trailing twelve-month coverage of 1.07x the declared distributions for the second quarter of 2019.

OpCo's Ethylene Sales Agreement with Westlake is designed to provide for stable and predictable cash flows. The agreement provides that 95% of OpCo's ethylene production is sold to Westlake for a cash margin of $0.10 per pound, net of operating costs, maintenance capital expenditures and reserves for future turnaround expenditures.

"Anchored by strong production volumes and with the acquisition of incremental interest in OpCo at the beginning of the year, we expect solid performance in the second half of the year," said Albert Chao, President and Chief Executive Officer. "This quarter we increased our distribution for the eighteenth consecutive quarter, delivering sustained value to our unitholders. We are continuing to evaluate all opportunities available to us, including growth through acquisition and margin expansion, as a means to further grow our cash flows and maintain a path of long-term distribution growth to our unitholders."

The statements in this release and the related teleconference relating to matters that are not historical facts, such as those with respect to performance in the second half of 2019 and the potential for future growth of cash flows and distributions, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to, operating difficulties; the volume of ethylene that we are able to sell; the price at which we are able to sell ethylene; changes in the price and availability of feedstocks; changes in prevailing economic conditions; actions of Westlake Chemical Corporation; actions of third parties; inclement or hazardous weather conditions, including flooding, and the physical impacts of climate change; environmental hazards; changes in laws and regulations (or the interpretation thereof); inability to acquire or maintain necessary permits; inability to obtain necessary production equipment or replacement parts; technical difficulties or failures; labor disputes; difficulty collecting receivables; inability of our customers to take delivery; fires, explosions or other industrial accidents; our ability to borrow funds and access capital markets; and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to the Partnership's Annual Report on Form 10-K for the year ended December 31, 2018, which was filed with the SEC in March 2019.

This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as being attributable to income that is effectively connected with a United States trade or business. Accordingly, the Partnership's distributions to non-U.S. investors are subject to federal income tax withholding at the highest applicable effective tax rate.

Use of Non-GAAP Financial Measures

The body of accounting principles generally accepted in the United States is commonly referred to as "GAAP." For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as a numerical measure of a registrant's historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with GAAP in the statement of income, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. The non-GAAP financial measures described in this Form 10-Q are not substitutes for the GAAP measures of earnings and cash flows. We use each of MLP distributable cash flow and EBITDA to analyze our performance. We define distributable cash flow as net income plus depreciation, amortization and disposition of property, plant and equipment, less contributions for turnaround reserves, maintenance capital expenditures and mark-to-market adjustment on derivative contracts. We define MLP distributable cash flow as distributable cash flow less distributable cash flow attributable to Westlake's noncontrolling interest in OpCo and distributions attributable to the incentive distribution rights holder. MLP distributable cash flow does not reflect changes in working capital balances. We define EBITDA as net income before interest expense, income taxes, depreciation and amortization. MLP distributable cash flow and EBITDA are non-GAAP supplemental financial measures that management and external users of our consolidated financial statements, such as industry analysts, investors, lenders and rating agencies, may use to assess our operating performance as compared to other publicly traded partnerships, our ability to incur and service debt and fund capital expenditures, and the viability of acquisitions and other capital expenditure projects and the returns on investment of various investment opportunities. We believe that the presentation of MLP distributable cash flow and EBITDA provides useful information to investors in assessing our financial condition and results of operations. The GAAP measures most directly comparable to MLP distributable cash flow are net income and net cash provided by operating activities. MLP distributable cash flow should not be considered as an alternative to GAAP net income or net cash provided by operating activities. MLP distributable cash flow has important limitations as an analytical tool because it excludes some but not all items that affect net income and net cash provided by operating activities. The GAAP measures most directly comparable to EBITDA are net income, income from operations and net cash provided by operating activities, but EBITDA should not be considered an alternative to such GAAP measures. EBITDA has important limitations as an analytical tool because it excludes (1) interest expense, which is a necessary element of our costs and ability to generate revenues because we have borrowed money to finance our operations, (2) depreciation, which is a necessary element of our costs and ability to generate revenues because we use capital assets and (3) income taxes, which is a necessary element of our operations in the jurisdictions we operate in. MLP distributable cash flow and EBITDA should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP.

Westlake Chemical Partners LP

Westlake Chemical Partners is a limited partnership formed by Westlake Chemical Corporation to operate, acquire and develop ethylene production facilities and other qualified assets. Headquartered in Houston, the Partnership owns an 22.8% interest in Westlake Chemical OpCo LP. Westlake Chemical OpCo LP's assets consist of three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana and an ethylene pipeline. For more information about Westlake Chemical Partners LP, please visit http://www.wlkpartners.com.

Westlake Chemical Partners LP Conference Call Information:

A conference call to discuss Westlake Chemical Partners' second quarter 2019 results will be held Tuesday, August 6, 2019 at 12:00 PM Eastern Time (11:00 AM Central Time). To access the conference call, dial (855) 765-5686 or (234) 386-2848 for international callers, approximately 10 minutes prior to the scheduled start time and reference passcode 219 92 32.

A replay of the conference call will be available beginning two hours after its conclusion until 11:59 p.m. Eastern Time on August 13, 2019. To hear a replay, dial (855) 859-2056 or (404) 537-3406 for international callers. The replay passcode is 219 92 32.

The conference call will also be available via webcast at: https://edge.media-server.com/mmc/p/puc8ymnz and the earnings release can be obtained via the Partnership web page at: http://investors.wlkpartners.com/CorporateProfile.

 

WESTLAKE CHEMICAL PARTNERS LP ("WESTLAKE PARTNERS")

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2019

 

2018

 

2019

 

2018

 

 

(In thousands of dollars, except per unit data)

Revenue

 

 

 

 

 

 

 

 

Net sales—Westlake Chemical Corporation ("Westlake")

 

$

230,047

 

 

$

253,673

 

 

$

487,087

 

 

$

488,704

 

Net co-product, ethylene and other sales—third parties

 

40,015

 

 

48,302

 

 

82,061

 

 

97,543

 

Total net sales

 

270,062

 

 

301,975

 

 

569,148

 

 

586,247

 

Cost of sales

 

178,104

 

 

204,857

 

 

386,536

 

 

396,624

 

Gross profit

 

91,958

 

 

97,118

 

 

182,612

 

 

189,623

 

Selling, general and administrative expenses

 

7,639

 

 

7,375

 

 

14,612

 

 

14,508

 

Income from operations

 

84,319

 

 

89,743

 

 

168,000

 

 

175,115

 

Other income (expense)

 

 

 

 

 

 

 

 

Interest expense—Westlake

 

(5,125

)

 

(5,547

)

 

(11,025

)

 

(10,413

)

Other income, net

 

1,153

 

 

583

 

 

1,968

 

 

1,074

 

Income before income taxes

 

80,347

 

 

84,779

 

 

158,943

 

 

165,776

 

Income tax provision

 

237

 

 

303

 

 

437

 

 

586

 

Net income

 

80,110

 

 

84,476

 

 

158,506

 

 

165,190

 

Less: Net income attributable to noncontrolling interests in Westlake Chemical OpCo LP ("OpCo")

 

66,377

 

 

71,719

 

 

129,818

 

 

140,138

 

Net income attributable to Westlake Partners

 

$

13,733

 

 

$

12,757

 

 

$

28,688

 

 

$

25,052

 

 

 

 

 

 

 

 

 

 

Net income per limited partners unit attributable to Westlake Partners (basic and diluted)

 

 

 

 

 

 

 

 

Common units

 

$

0.39

 

 

$

0.40

 

 

$

0.85

 

 

$

0.75

 

 

 

 

 

 

 

 

 

 

Distributions declared per unit

 

$

0.4579

 

 

$

0.4088

 

 

$

0.9031

 

 

$

0.8063

 

 

 

 

 

 

 

 

 

 

MLP distributable cash flow

 

$

16,422

 

 

$

15,966

 

 

$

33,977

 

 

$

30,476

 

 

 

 

 

 

 

 

 

 

Distributions declared

 

 

 

 

 

 

 

 

Limited partner units—publicly and privately held

 

$

9,646

 

 

$

7,406

 

 

$

19,025

 

 

$

14,607

 

Limited partner units—Westlake

 

6,467

 

 

5,773

 

 

12,754

 

 

11,386

 

Incentive distribution rights

 

 

 

 

 

 

 

733

 

Total distributions declared

 

$

16,113

 

 

$

13,179

 

 

$

31,779

 

 

$

26,726

 

EBITDA

 

$

112,329

 

 

$

117,912

 

 

$

223,669

 

 

$

231,473

 

 
 

WESTLAKE CHEMICAL PARTNERS LP

 

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

 

 

June 30,
2019

 

December 31,
2018

 

 

(In thousands of dollars)

ASSETS

 

 

 

 

Current assets

 

 

 

 

Cash and cash equivalents

 

$

17,473

 

 

$

19,744

 

Receivable under the Investment Management Agreement—Westlake Chemical Corporation ("Westlake")

 

141,327

 

 

148,956

 

Accounts receivable, net—Westlake

 

38,995

 

 

57,280

 

Accounts receivable, net—third parties

 

20,435

 

 

16,404

 

Inventories

 

4,029

 

 

4,388

 

Prepaid expenses and other current assets

 

95

 

 

370

 

Total current assets

 

222,354

 

 

247,142

 

Property, plant and equipment, net

 

1,129,083

 

 

1,148,265

 

Other assets, net

 

59,467

 

 

66,718

 

Total assets

 

$

1,410,904

 

 

$

1,462,125

 

 

 

 

 

 

LIABILITIES AND EQUITY

 

 

 

 

Current liabilities (accounts payable and accrued liabilities)

 

$

36,313

 

 

$

48,772

 

Long-term debt payable to Westlake

 

399,674

 

 

477,608

 

Other liabilities

 

2,803

 

 

1,664

 

Total liabilities

 

438,790

 

 

528,044

 

Common unitholders—publicly and privately held

 

471,944

 

 

409,608

 

Common unitholder—Westlake

 

48,419

 

 

48,774

 

General partner—Westlake

 

(242,572

)

 

(242,572

)

Total Westlake Partners partners' capital

 

277,791

 

 

215,810

 

Noncontrolling interest in OpCo

 

694,323

 

 

718,271

 

Total equity

 

972,114

 

 

934,081

 

Total liabilities and equity

 

$

1,410,904

 

 

$

1,462,125

 

 
 

WESTLAKE CHEMICAL PARTNERS LP

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

Six Months Ended June 30,

 

 

2019

 

2018

 

 

(In thousands of dollars)

Cash flows from operating activities

 

 

 

 

Net income

 

$

158,506

 

 

$

165,190

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

Depreciation and amortization

 

53,701

 

 

55,284

 

Other balance sheet changes

 

1,465

 

 

97

 

Net cash provided by operating activities

 

213,672

 

 

220,571

 

Cash flows from investing activities

 

 

 

 

Additions to property, plant and equipment

 

(25,582

)

 

(16,620

)

Maturities of investments with Westlake under the Investment Management Agreement

 

344,445

 

 

178,000

 

Investments with Westlake under the Investment Management Agreement

 

(336,445

)

 

(185,000

)

Other

 

46

 

 

251

 

Net cash used for investing activities

 

(17,536

)

 

(23,369

)

Cash flows from financing activities

 

 

 

 

Net proceeds from private placement of common units

 

62,916

 

 

 

Proceeds from debt payable to Westlake

 

123,511

 

 

3,648

 

Repayment of debt payable to Westlake

 

(201,445

)

 

 

Quarterly distributions to noncontrolling interest retained in OpCo by Westlake

 

(153,766

)

 

(172,758

)

Quarterly distributions to unitholders

 

(29,623

)

 

(26,617

)

Net cash used for financing activities

 

(198,407

)

 

(195,727

)

Net increase (decrease) in cash and cash equivalents

 

(2,271

)

 

1,475

 

Cash and cash equivalents at beginning of period

 

19,744

 

 

27,008

 

Cash and cash equivalents at end of period

 

$

17,473

 

 

$

28,483

 

 
 

WESTLAKE CHEMICAL PARTNERS LP

 

RECONCILIATION OF MLP DISTRIBUTABLE CASH FLOW TO NET INCOME

AND NET CASH PROVIDED BY OPERATING ACTIVITIES

(Unaudited)

 

 

 

Three Months
Ended March 31,

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2019

 

2019

 

2018

 

2019

 

2018

 

 

(In thousands of dollars)

Net cash provided by operating activities

 

$

113,499

 

 

$

100,173

 

 

$

114,349

 

 

$

213,672

 

 

$

220,571

 

Changes in operating assets and liabilities and other

 

(35,103

)

 

(20,063

)

 

(29,873

)

 

(55,166

)

 

(55,381

)

Net Income

 

78,396

 

 

80,110

 

 

84,476

 

 

158,506

 

 

165,190

 

Add:

 

 

 

 

 

 

 

 

 

 

Depreciation, amortization and disposition of property, plant and equipment

 

27,302

 

 

26,903

 

 

27,586

 

 

54,205

 

 

55,851

 

Mark-to-market adjustment loss (gain) on derivative contracts

 

(715

)

 

516

 

 

 

 

(199

)

 

 

Less:

 

 

 

 

 

 

 

 

 

 

Contribution to turnaround reserves

 

(3,848

)

 

(3,889

)

 

(4,204

)

 

(7,737

)

 

(8,352

)

Maintenance capital expenditures

 

(11,320

)

 

(11,725

)

 

(5,825

)

 

(23,045

)

 

(13,804

)

Incentive distribution rights

 

 

 

 

 

 

 

 

 

(733

)

Distributable cash flow attributable to noncontrolling interest in OpCo

 

(72,260

)

 

(75,493

)

 

(86,067

)

 

(147,753

)

 

(167,676

)

MLP distributable cash flow

 

$

17,555

 

 

$

16,422

 

 

$

15,966

 

 

$

33,977

 

 

$

30,476

 

 
 

WESTLAKE CHEMICAL PARTNERS LP

 

RECONCILIATION OF EBITDA TO NET INCOME, INCOME FROM OPERATIONS AND NET CASH

PROVIDED BY OPERATING ACTIVITIES

(Unaudited)

 

 

 

Three Months
Ended March 31,

 

Three Months Ended June 30,

 

Six Months Ended June 30,

 

 

2019

 

2019

 

2018

 

2019

 

2018

 

 

(In thousands of dollars)

Net cash provided by operating activities

 

$

113,499

 

 

$

100,173

 

 

$

114,349

 

 

$

213,672

 

 

$

220,571

 

Changes in operating assets and liabilities and other

 

(35,103

)

 

(20,063

)

 

(29,873

)

 

(55,166

)

 

(55,381

)

Net Income

 

78,396

 

 

80,110

 

 

84,476

 

 

158,506

 

 

165,190

 

Less:

 

 

 

 

 

 

 

 

 

 

Other income, net

 

815

 

 

1,153

 

 

583

 

 

1,968

 

 

1,074

 

Interest expense

 

(5,900

)

 

(5,125

)

 

(5,547

)

 

(11,025

)

 

(10,413

)

Income tax provision

 

(200

)

 

(237

)

 

(303

)

 

(437

)

 

(586

)

Income from operations

 

83,681

 

 

84,319

 

 

89,743

 

 

168,000

 

 

175,115

 

Add:

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

26,844

 

 

26,857

 

 

27,586

 

 

53,701

 

 

55,284

 

Other income, net

 

815

 

 

1,153

 

 

583

 

 

1,968

 

 

1,074

 

EBITDA

 

$

111,340

 

 

$

112,329

 

 

$

117,912

 

 

$

223,669

 

 

$

231,473

 

 

Source: Westlake Chemical Partners LP

(713) 585-2900
Investors—Steve Bender
Media—L. Benjamin Ederington